Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 22/6/2017
SIETES contiene 91846 citas

 
 
 1 a 20 de 5538 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Becker WC, Fiellin DA. Abuse-deterrent opioid formulations - Putting the potential benefits into perspective. N Engl J Med 2017;376:2103-5. [Ref.ID 101625]
2. Cita con resumen
Cowley NJ, Owen A, Shiels SC, Millar J, Woolley R, Ives N, Osman H, Moss P, Bion FJ. Safety and efficacy of antiviral therapy for prevention of cytomegalovirus reactivation in immunocompetent critically ill patients: a randomized clinical trial. JAMA Intern Med 2017;177:774-83. [Ref.ID 101617]
3. Cita con resumen
Anónimo. WHO’s travel expenses exceed what it spends on some diseases. DIA Daily 2017:1. [Ref.ID 101587]
4.Enlace a cita original Cita con resumen
Graner S, Svensson T, Beau A-B, Damase-Michel C, Engeland A, Furu K, Hviid A, Haberg SE, Molgaard-Nielsen D, Pasternak B, Kieler H. Neuraminidase inhibitors during pregnancy and risk of adverse neonatal outcomes and congenital malformations: population based European register study. BMJ 2017;356:j629. [Ref.ID 101465]
6. Cita con resumen
Anónimo. Extraits de racine de Pelargonium et rhume. Prescrire 2017;37:8. [Ref.ID 101358]
7.Enlace a cita original
Hawcutt DB, Russell N-J, Maqsood H, Kouranloo K, Gomberg S, Waitt C, Sharp A, Riordan A, Turner MA. Spontaneous adverse drug reaction reports for neonates and infants in the UK 2001–2010: content and utility analysis . Br J Clin Pharmacol 2016;82:1601-12. [Ref.ID 101026]
9. Cita con resumen
Keh D, Trips E, Marx G, Wirtz SP, Abduljawwad E, Bercker S, Bogatsch H, Briegel J, Engel C, Gerlach H, Goldmann A, Kuhn SO, Hüter L, Meier-Hellmann A, Nierhaus A, Kluge S, Lehmke J, Loeffler M, Oppert M, Resener K, Schädler D, Schuerholz T, Simon P, Weiler N, Weyland A, Reinhart K, Brunkhorst FM, SepNet-Critical Care Trials Group. Effect of hydrocortisone on development of shock among patients with severe sepsis: the HYPRESS randomized clinical trial. JAMA 2016;316:1775-85. [Ref.ID 100934]
10. Cita con resumen
Bar KJ, Sneller MC, Harrison LJ, Justement JS, Overton ET, Petrone ME, Salantes DB, Seamon CA, Scheinfeld B, Kwan RW, Learn G, Proschan MA, Kreider EF, Blazkova J, Bardsley M, Refsland EW, Messer M, Clarridge KE, Tustin NB, Madden PJ, Oden K, O'Dell SJ, Jacoki B, Shiakolas AR, Tressler RL, Doria-Rose NA, Bailer RT, Ledgerwood JE, Capparelli EV, Lynch RM, Graham BS, Moir S, Koup RA, Mascola JR, Hoxie JA, Fauci AS, Tebas P, Chun T-W. Effect of HIV antibody VRC01 on viral rebound after treatment interruption. N Engl J Med 2016:9 de noviembre. [Ref.ID 100922]
11. Cita con resumen
12. Cita con resumen
Smith JA, Woodcock A. Chronic cough. N Engl J Med 2016;375:1544-51. [Ref.ID 100909]
13. Cita con resumen
Anónimo. Various states approve recreational, medical marijuana use. DIA Daily 2016:7. [Ref.ID 100907]
14. Cita con resumen
Anónimo. Sofosuvir: hypertensions artérielles pulmonaires?. Prescrire 2016;36:746. [Ref.ID 100893]
16. Cita con resumen
Anónimo. Influenza vaccine for 2016-2017. Med Lett Drugs Ther 2016;58:127-30. [Ref.ID 100884]
18. Cita con resumen
Anónimo. Gilead’s hepatitis C drug sales decline. DIA Daily 2016:11. [Ref.ID 100874]
19. Cita con resumen
Anónimo. Ibalizumab shows promising results treating multi-drug-resistant HIV. DIA Daily 2016:4. [Ref.ID 100869]
Seleccionar todas
 
 1 a 20 de 5538 siguiente >>